Philips healthcare sales fall in 3Q
Emerging markets, such as the one in China, saved Philips from a bleak showing in the healthcare marketplace last quarter.
Philips healthcare sales fall in 3Q
Emerging markets, such as the one in China, saved Philips from a bleak showing in the healthcare marketplace last quarter. The growth was not enough to keep the company in the black, however, even just in this sector. Financials released Oct. 12 for 3Q09 show that Philips suffered a 4% decline year-over-year in healthcare sales globally. Leading the trouble areas were declines in the U.S. in imaging systems, clinical care systems, and patient monitoring. Those losses were partially offset by double-digit growth in emerging markets, helping the healthcare business to do better than other Philips businesses. Company-wide sales in the third quarter went down 11% compared to 3Q2008, reflecting continuing weakness in consumer and professional markets. Even so, the company managed a profitability of 6.8% of sales in the quarter, among the highest in recent years. Company execs ascribed the net profit to strong fundamentals and managing costs proactively.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
